Difference between revisions of "Template:Breast cancer staging"
m (→Staging: Delinked) |
(→Staging: +Image) |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
===Staging=== | ===Staging=== | ||
− | Stage by the TNM system as follows. | + | Stage by the TNM system as follows in sections below. |
− | |||
− | |||
+ | Also, look for any angiolymphatic invasion. If present, check whether it reaches outside the tumor, and if so, how far.<ref name=Stanford>{{cite web|url=http://surgpathcriteria.stanford.edu/breast/infductcabr/grading.html|title=Infiltrating Ductal Carcinoma of the Breast (Carcinoma of No Special Type)|website=Stanford Medical School|accessdate=2019-10-02}}</ref> Give greatest dimension {{Moderate-begin}},or 3 dimensions, generally by adding up the estimated thicknesses of involved slices{{Comprehensive-end}}.<ref name=Stanford/> | ||
+ | {|class="wikitable" | ||
+ | | | ||
====Primary Tumor (T)==== | ====Primary Tumor (T)==== | ||
'''T'''umor – Depends on the tumor at the primary site of origin, as follows:<ref name=Alkabban2019>Originally copied from {{cite web|url=https://www.ncbi.nlm.nih.gov/books/NBK482286/|title=Cancer, Breast|author=Fadi M. Alkabban; Troy Ferguson|website=National Center for Biotechnology Information}} Last Update: June 4, 2019. [http://creativecommons.org/licenses/by/4.0/ Creative Commons Attribution 4.0 International License]</ref> | '''T'''umor – Depends on the tumor at the primary site of origin, as follows:<ref name=Alkabban2019>Originally copied from {{cite web|url=https://www.ncbi.nlm.nih.gov/books/NBK482286/|title=Cancer, Breast|author=Fadi M. Alkabban; Troy Ferguson|website=National Center for Biotechnology Information}} Last Update: June 4, 2019. [http://creativecommons.org/licenses/by/4.0/ Creative Commons Attribution 4.0 International License]</ref> | ||
*TX: inability to assess that site | *TX: inability to assess that site | ||
*Tis: [[ductal carcinoma in situ]] (DCIS), [[lobular carcinoma in situ]] (LCIS) or [[Paget's disease of the breast]] | *Tis: [[ductal carcinoma in situ]] (DCIS), [[lobular carcinoma in situ]] (LCIS) or [[Paget's disease of the breast]] | ||
+ | [[File:Measurement of tumor size on two microscopy slides.jpg|thumb|220px|Measurements can be made by marking the tumor on microscopy, and then measuring between the markings, which may overlap between multiple slides as shown.]] | ||
*T1: Less than 2 cm | *T1: Less than 2 cm | ||
:*T1a: 0.1 to 0.5 cm | :*T1a: 0.1 to 0.5 cm | ||
Line 20: | Line 22: | ||
:*T4d: [[Inflammatory breast cancer]], a clinical circumstance where typical skin changes involve at least a third of the breast. | :*T4d: [[Inflammatory breast cancer]], a clinical circumstance where typical skin changes involve at least a third of the breast. | ||
− | ===Regional Lymph Nodes (N)=== | + | ====Regional Lymph Nodes (N)==== |
Lymph '''N'''ode – The lymph node values depend on the number, size and location of breast cancer cell deposits in various regional lymph nodes, such as the armpit (axillary lymph nodes), the collar area (supraclavicular lymph nodes), and inside the chest (internal mammary lymph nodes.)<ref name="pmid3347753">{{cite journal |vauthors=Scatarige JC, Fishman EK, Zinreich ES, Brem RF, Almaraz R |title=Internal mammary lymphadenopathy in breast carcinoma: CT appraisal of anatomic distribution |journal=Radiology |volume=167 |issue=1 |pages=89–91 |date=April 1988 |pmid=3347753 |doi= 10.1148/radiology.167.1.3347753|url=}}</ref><ref name="pmid2217975">{{cite journal |vauthors=Scatarige JC, Boxen I, Smathers RL |title=Internal mammary lymphadenopathy: imaging of a vital lymphatic pathway in breast cancer |journal=Radiographics |volume=10 |issue=5 |pages=857–70 |date=September 1990 |pmid=2217975 |doi= 10.1148/radiographics.10.5.2217975|url=}}</ref> Each stage is as follows:<ref name=Alkabban2019/> | Lymph '''N'''ode – The lymph node values depend on the number, size and location of breast cancer cell deposits in various regional lymph nodes, such as the armpit (axillary lymph nodes), the collar area (supraclavicular lymph nodes), and inside the chest (internal mammary lymph nodes.)<ref name="pmid3347753">{{cite journal |vauthors=Scatarige JC, Fishman EK, Zinreich ES, Brem RF, Almaraz R |title=Internal mammary lymphadenopathy in breast carcinoma: CT appraisal of anatomic distribution |journal=Radiology |volume=167 |issue=1 |pages=89–91 |date=April 1988 |pmid=3347753 |doi= 10.1148/radiology.167.1.3347753|url=}}</ref><ref name="pmid2217975">{{cite journal |vauthors=Scatarige JC, Boxen I, Smathers RL |title=Internal mammary lymphadenopathy: imaging of a vital lymphatic pathway in breast cancer |journal=Radiographics |volume=10 |issue=5 |pages=857–70 |date=September 1990 |pmid=2217975 |doi= 10.1148/radiographics.10.5.2217975|url=}}</ref> Each stage is as follows:<ref name=Alkabban2019/> | ||
*N0: There is some nuance to the official definitions for N0 disease, which includes: | *N0: There is some nuance to the official definitions for N0 disease, which includes: | ||
Line 38: | Line 40: | ||
*M1: Distant detectable metastases as determined by classic clinical and radiographic means, and/or metastasis that are histologically larger than 0.2 mm. | *M1: Distant detectable metastases as determined by classic clinical and radiographic means, and/or metastasis that are histologically larger than 0.2 mm. | ||
− | ===Overall stage=== | + | ====Overall stage==== |
A combination of T, N and M, as follows:<ref name=Alkabban2019/> | A combination of T, N and M, as follows:<ref name=Alkabban2019/> | ||
*Stage 0: Tis | *Stage 0: Tis | ||
Line 44: | Line 46: | ||
*Stage II: T2N0, T3N0 T0N1, T1N1, or T2N1 | *Stage II: T2N0, T3N0 T0N1, T1N1, or T2N1 | ||
*Stage III: Invasion into skin and/or ribs, matted lymph nodes, T3N1, T0N2, T1N2, T2N2, T3N2, AnyT N3, T4 any N, locally advanced breast cancer | *Stage III: Invasion into skin and/or ribs, matted lymph nodes, T3N1, T0N2, T1N2, T2N2, T3N2, AnyT N3, T4 any N, locally advanced breast cancer | ||
− | *Stage IV: M1, advanced breast cancer<noinclude> | + | *Stage IV: M1, advanced breast cancer |
+ | |}<noinclude> | ||
{{Bottom}} | {{Bottom}} | ||
</noinclude> | </noinclude> |
Revision as of 19:28, 13 September 2021
Contents
Staging
Stage by the TNM system as follows in sections below.
Also, look for any angiolymphatic invasion. If present, check whether it reaches outside the tumor, and if so, how far.[1] Give greatest dimension (,or 3 dimensions, generally by adding up the estimated thicknesses of involved slices)).[1]
Primary Tumor (T)Tumor – Depends on the tumor at the primary site of origin, as follows:[2]
Regional Lymph Nodes (N)Lymph Node – The lymph node values depend on the number, size and location of breast cancer cell deposits in various regional lymph nodes, such as the armpit (axillary lymph nodes), the collar area (supraclavicular lymph nodes), and inside the chest (internal mammary lymph nodes.)[3][4] Each stage is as follows:[2]
Critical numbers of involved nodes: 1-3, 4-9, and 10 and over. Note any extranodal extension.[1]
Distant Metastases (M)
Overall stageA combination of T, N and M, as follows:[2]
|
Notes
Main page
References
- ↑ 1.0 1.1 1.2 1.3 1.4 . Infiltrating Ductal Carcinoma of the Breast (Carcinoma of No Special Type). Stanford Medical School. Retrieved on 2019-10-02.
- ↑ 2.0 2.1 2.2 Originally copied from Fadi M. Alkabban; Troy Ferguson. Cancer, Breast. National Center for Biotechnology Information. Last Update: June 4, 2019. Creative Commons Attribution 4.0 International License
- ↑ "Internal mammary lymphadenopathy in breast carcinoma: CT appraisal of anatomic distribution ". Radiology 167 (1): 89–91. April 1988. doi: . PMID 3347753.
- ↑ "Internal mammary lymphadenopathy: imaging of a vital lymphatic pathway in breast cancer ". Radiographics 10 (5): 857–70. September 1990. doi: . PMID 2217975.
Image sources